Table 3

Prevalence of Abs to SS-A/Ro and SS-B/La in patients with SS with ACA and those without ACA

ACAAbs to SS-A/RoAbs to SS-B/La
Seropositive group6/28 (21.4%)0/28 (0%)
Seronegative group98/174 (56.3%)23/174 (13.2%)
Statistical analysisp=0.0013p=0.0495